Anteris Technologies Global CORP. (AVR) — 10-Q Filings
All 10-Q filings from Anteris Technologies Global CORP.. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (3)
-
Anteris's Losses Widen on Soaring R&D, Cash Dwindles
— Nov 12, 2025 Risk: high
Anteris Technologies Global Corp. (AVR) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $65.202 million, up f -
Anteris Posts Zero Revenue, Deepens Loss Amid DurAVR Trials
— Aug 11, 2025 Risk: high
Anteris Technologies Global Corp. (AVR) reported no revenue for the quarter ended June 30, 2025, consistent with its pre-commercial stage as a medical device co -
Anteris Technologies Global Corp. Files Q1 2025 10-Q
— May 13, 2025 Risk: low
Anteris Technologies Global Corp. filed its quarterly report for the period ending March 31, 2025. The company, incorporated in Delaware, is involved in the ort
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX